Jason Adair Sells 688 Shares of Liquidia (NASDAQ:LQDA) Stock

Liquidia Corporation (NASDAQ:LQDA) insider Jason Adair sold 688 shares of the firm’s stock in a transaction that occurred on Monday, January 26th. The stock was sold at an average price of $41.65, for a total transaction of $28,655.20. Following the completion of the transaction, the insider directly owned 211,169 shares in the company, valued at approximately $8,795,188.85. The trade was a 0.32% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Jason Adair also recently made the following trade(s):

• On Monday, January 12th, Jason Adair sold 13,548 shares of Liquidia stock. The stock was sold at an average price of $37.43, for a total value of $507,101.64.
• On Monday, December 1st, Jason Adair sold 693 shares of Liquidia stock. The stock was sold at an average price of $32.19, for a total value of $22,307.67.
• On Tuesday, November 18th, Jason Adair sold 35,656 shares of Liquidia stock. The stock was sold at an average price of $30.03, for a total transaction of $1,070,749.68.

Liquidia Stock Down 1.3%

Shares of NASDAQ LQDA traded down $0.56 during midday trading on Wednesday, reaching $41.91. 1,383,798 shares of the company’s stock traded hands, compared to its average volume of 2,368,033. The stock’s 50 day simple moving average is $34.65 and its 200-day simple moving average is $27.49. The company has a quick ratio of 1.96, a current ratio of 2.20 and a debt-to-equity ratio of 6.19. Liquidia Corporation has a one year low of $11.26 and a one year high of $43.42. The company has a market cap of $3.65 billion, a price-to-earnings ratio of -29.10, a P/E/G ratio of 1.18 and a beta of 0.48.

Liquidia (NASDAQ:LQDA) last issued its earnings results on Monday, November 3rd. The company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.45) by $0.41. Liquidia had a negative return on equity of 296.78% and a negative net margin of 176.04%.The company had revenue of $54.34 million during the quarter, compared to analyst estimates of $18.86 million. The business’s revenue for the quarter was up 1106.7% compared to the same quarter last year. On average, analysts predict that Liquidia Corporation will post -1.51 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have commented on LQDA. Needham & Company LLC lifted their price target on Liquidia from $36.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Jefferies Financial Group boosted their price objective on shares of Liquidia from $45.00 to $55.00 and gave the company a “buy” rating in a research report on Tuesday, January 13th. Zacks Research raised Liquidia from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 13th. Raymond James Financial reiterated a “strong-buy” rating and issued a $47.00 target price on shares of Liquidia in a research note on Tuesday, November 4th. Finally, Wells Fargo & Company started coverage on shares of Liquidia in a research note on Monday, October 20th. They issued an “overweight” rating and a $31.00 price target for the company. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $39.67.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LQDA. NewEdge Advisors LLC acquired a new position in Liquidia during the 2nd quarter worth $25,000. Skandinaviska Enskilda Banken AB publ bought a new stake in shares of Liquidia in the third quarter worth $30,000. FNY Investment Advisers LLC acquired a new stake in shares of Liquidia in the 3rd quarter valued at approximately $34,000. Steward Partners Investment Advisory LLC boosted its position in Liquidia by 24.0% during the second quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company’s stock worth $77,000 after purchasing an additional 1,200 shares during the period. Finally, Tower Research Capital LLC TRC grew its stake in shares of Liquidia by 281.2% in the second quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company’s stock valued at $83,000 after acquiring an additional 4,927 shares in the last quarter. Institutional investors own 64.54% of the company’s stock.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).